Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX NYSE:LH NASDAQ:NTRA NASDAQ:RDNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$180.71-1.2%$175.81$146.17▼$185.62$20.45B0.54688,961 shs642,154 shsLHLabcorp$275.33-0.9%$266.21$209.38▼$283.47$23.10B0.85433,652 shs426,988 shsNTRANatera$172.16+2.2%$155.45$117.27▼$183.00$23.13B1.68945,987 shs795,498 shsRDNTRadNet$74.99+1.3%$63.44$45.00▼$93.65$5.69B1.54586,183 shs985,612 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics-1.18%-1.00%+0.58%+0.98%+17.05%LHLabcorp-0.98%-0.60%+1.75%+6.16%+24.51%NTRANatera+2.17%+2.85%+5.61%+2.75%+36.08%RDNTRadNet+1.32%+4.17%+11.18%+32.58%+10.62%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$180.71-1.2%$175.81$146.17▼$185.62$20.45B0.54688,961 shs642,154 shsLHLabcorp$275.33-0.9%$266.21$209.38▼$283.47$23.10B0.85433,652 shs426,988 shsNTRANatera$172.16+2.2%$155.45$117.27▼$183.00$23.13B1.68945,987 shs795,498 shsRDNTRadNet$74.99+1.3%$63.44$45.00▼$93.65$5.69B1.54586,183 shs985,612 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics-1.18%-1.00%+0.58%+0.98%+17.05%LHLabcorp-0.98%-0.60%+1.75%+6.16%+24.51%NTRANatera+2.17%+2.85%+5.61%+2.75%+36.08%RDNTRadNet+1.32%+4.17%+11.18%+32.58%+10.62%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.50Moderate Buy$186.002.93% UpsideLHLabcorp 2.62Moderate Buy$290.335.45% UpsideNTRANatera 3.06Buy$194.0012.69% UpsideRDNTRadNet 3.25Buy$76.802.41% UpsideCurrent Analyst Ratings BreakdownLatest RDNT, NTRA, LH, and DGX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/3/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$60.00 ➝ $79.009/3/2025RDNTRadNetTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$74.00 ➝ $81.009/2/2025NTRANateraRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform$268.008/25/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$311.008/25/2025DGXQuest DiagnosticsBaird R WSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/25/2025DGXQuest DiagnosticsRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Neutral$194.008/18/2025RDNTRadNetZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/15/2025NTRANateraStephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$183.008/13/2025RDNTRadNetRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingStrong-Buy$66.00 ➝ $75.008/11/2025RDNTRadNetMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOverweight8/11/2025NTRANateraPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$210.00 ➝ $220.00(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$10.52B1.92$13.35 per share13.54$61.38 per share2.94LHLabcorp$13.01B1.76$22.19 per share12.41$96.27 per share2.86NTRANatera$1.70B13.92N/AN/A$9.05 per share19.02RDNTRadNet$1.83B3.15$3.53 per share21.25$15.31 per share4.90Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$8.3521.6417.232.439.01%15.24%6.64%10/28/2025 (Estimated)LHLabcorp$746M$9.0630.3915.701.785.66%15.45%7.02%10/23/2025 (Estimated)NTRANatera-$190.43M-$1.91N/AN/AN/A-12.89%-22.22%-15.03%11/11/2025 (Estimated)RDNTRadNet$2.79M-$0.20N/A141.49N/A-0.78%2.41%0.82%11/10/2025 (Estimated)Latest RDNT, NTRA, LH, and DGX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/10/2025Q2 2025RDNTRadNet$0.17$0.31+$0.14$0.43$488.06 million$498.23 million8/7/2025Q2 2025NTRANatera-$0.60-$0.74-$0.14-$0.74$476.84 million$546.60 million7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.77%N/A38.32%14 YearsLHLabcorp$2.881.05%N/A31.79%N/ANTRANateraN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ALatest RDNT, NTRA, LH, and DGX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/13/2025DGXQuest Diagnosticsquarterly$0.801.79%10/3/202510/3/202510/20/20257/10/2025LHLabcorpquarterly$0.721.05%8/28/20258/28/20259/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.711.090.99LHLabcorp0.611.501.32NTRANateraN/A3.723.58RDNTRadNet0.912.002.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%LHLabcorp95.94%NTRANatera99.90%RDNTRadNet77.90%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%LHLabcorp0.84%NTRANatera5.63%RDNTRadNet5.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableLHLabcorp70,00083.10 million82.40 millionOptionableNTRANatera4,434137.25 million129.52 millionOptionableRDNTRadNet11,02176.92 million72.61 millionOptionableRDNT, NTRA, LH, and DGX HeadlinesRecent News About These CompaniesIntech Investment Management LLC Acquires 22,198 Shares of RadNet, Inc. $RDNTSeptember 15 at 3:19 AM | marketbeat.comInsider Selling: RadNet (NASDAQ:RDNT) COO Sells 10,000 Shares of StockSeptember 14 at 5:32 PM | marketbeat.comNorman Hames Sells 10,000 Shares of RadNet (NASDAQ:RDNT) StockSeptember 13 at 6:38 AM | insidertrades.comInsider Selling: RadNet (NASDAQ:RDNT) CEO Sells 500 Shares of StockSeptember 11, 2025 | insidertrades.comFred Alger Management LLC Raises Holdings in RadNet, Inc. $RDNTSeptember 11, 2025 | marketbeat.comAxiom Investors LLC DE Trims Stake in RadNet, Inc. $RDNTSeptember 10, 2025 | marketbeat.comRadNet, Inc. (RDNT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comRoyal Bank of Canada Increases Stake in RadNet, Inc. $RDNTSeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 27,655 Shares of RadNet, Inc. $RDNTSeptember 9, 2025 | marketbeat.comRadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025September 8, 2025 | globenewswire.comPunch & Associates Investment Management Inc. Raises Holdings in RadNet, Inc. $RDNTSeptember 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Acquires 712,270 Shares of RadNet, Inc. $RDNTSeptember 6, 2025 | marketbeat.comRadNet (NASDAQ:RDNT) Price Target Raised to $81.00September 6, 2025 | americanbankingnews.comBarclays Raises RadNet (NASDAQ:RDNT) Price Target to $79.00September 5, 2025 | marketbeat.comTruist Financial Forecasts Strong Price Appreciation for RadNet (NASDAQ:RDNT) StockSeptember 5, 2025 | marketbeat.com1 High-Flying Stock for Long-Term Investors and 2 We AvoidSeptember 4, 2025 | finance.yahoo.comRadNet price target raised to $81 from $74 at TruistSeptember 3, 2025 | msn.comRadNet price target raised to $79 from $60 at BarclaysSeptember 3, 2025 | msn.comRadNet, Inc. $RDNT Shares Acquired by Beck Mack & Oliver LLCSeptember 2, 2025 | marketbeat.comKingdon Capital Management L.L.C. Invests $3.83 Million in RadNet, Inc. $RDNTSeptember 1, 2025 | marketbeat.comAmeriprise Financial Inc. Increases Stake in RadNet, Inc. $RDNTSeptember 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCan AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025Buffett’s Wisdom Could Spell Trouble for Palantir ShortsBy Chris Markoch | August 26, 2025V2X Stock: Defense Underdog Riding a $4.3B Air Force ContractBy Nathan Reiff | August 24, 2025New Global Deals Boost These 2 Defense LeadersBy Gabriel Osorio-Mazilli | August 27, 2025Alphabet Stock Surges After Dodging Harsh Antitrust RemediesBy Ryan Hasson | September 3, 2025RDNT, NTRA, LH, and DGX Company DescriptionsQuest Diagnostics NYSE:DGX$180.71 -2.20 (-1.20%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$180.48 -0.23 (-0.13%) As of 09/15/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.Labcorp NYSE:LH$275.33 -2.62 (-0.94%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$275.46 +0.14 (+0.05%) As of 09/15/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Natera NASDAQ:NTRA$172.16 +3.65 (+2.17%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$172.08 -0.08 (-0.04%) As of 09/15/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.RadNet NASDAQ:RDNT$74.99 +0.98 (+1.32%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$75.00 +0.01 (+0.01%) As of 09/15/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Reddit Hits Record Highs: Why Wall Street Is Taking Notice Royal Caribbean's 33% Dividend Hike Signals Deeper Growth FuelCell Energy's Stock: Is a Fundamental Breakout Underway? After a Strong Wall Street Debut, Klarna's Real Work Begins MarketBeat Week in Review – 09/08 - 09/12 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
